Close Menu

Molecular Devices

The deal covers use within the life sciences, food and beverage research, and environmental testing markets.

NEW YORK (GenomeWeb News) – Molecular Devices today announced a global distribution agreement with Fluxion Biosciences covering its IonFlux instruments and consumables.
Molecular Devices also is providing support for all IonFlux Systems users as part of the deal, it said.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

New Product Watch: Jun 14, 2011

Premium

Affymetrix's Human Genome U133+ PM Array Strip, Molecular Devices' GenePix SL50 Slide Loader and GenePix Pro 7.2 Software

Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide.

Molecular Devices will also sell ChanTest's cell optimization services to Molecular Devices' customers worldwide using its PatchXpress 7000A, IonWorks Quattro, IonWorks Barracuda, and FLIPR Tetra systems.

Movers & Shakers: Jul 23, 2010

Premium

Didier Hirsch, Riaz Bandali

The acquisitions of AB Sciex and Molecular Devices helped Danaher's Medical Technologies segment increase its revenues 31 percent during the quarter.

The EPO has upheld Molecular Devices' patent cover patch-clamp technology, but the firm that opposed the patent said that it has been amended.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.